Health
Novel nanobody combinations protect cells from SARS-CoV-2 in vitro – Drug Target Review
By combining nanobodies targeting different regions of the SARS-CoV-2 Spike protein, researchers were able to protect cells from infection.
Posted: 14 January 2021 | Hannah Balfour (Drug Target Review) | No comments yet
By combining nanobodies targeting different regions of the SARS-CoV-2 Spike protein, researchers were able to protect cells from infection.
Researchers have developed combined nanobodies which can neutralise SARS-CoV-2, even if it mutates. According to the team, the nanobodies could be developed a drug treatment for use in those critically ill with COVID-19, the disease caused by SARS-CoV-2, or people that may not be…
-
Noosa News21 hours agoStudents say new facility would be better in rural areas of Queensland
-
General15 hours ago‘We are here for you’: PM to bring help to flood zones
-
General13 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening
-
Noosa News13 hours agoRates on hold; pressure builds for cuts in May